Cupid Ltd Doubles Net Profit, Targets ₹335 Cr Topline by FY26

In the second quarter of 2025, healthcare products manufacturer Cupid Ltd has reported a remarkable financial performance. The company's net profit more than doubled to ₹24 crore, up from ₹10 crore in the same period last year. This impressive growth was driven by a significant increase in total income, which surged to ₹90 crore in Q2 2025 compared to ₹47 crore in the year-ago quarter.

Cupid Ltd's Chairman and Managing Director, Aditya Kumar Halwasiya, attributed the strong results to capacity expansion and smarter procurement, which helped the company remove execution bottlenecks and build a durable growth engine. The company remains on track to achieve its ₹335 crore topline target for the financial year 2026 and expects the second half of the fiscal to be stronger than the first half, driven by strong order visibility and improving execution.

Furthermore, Cupid Ltd anticipates delivering a net profit of over ₹100 crore for the full year, showcasing its continued financial strength and growth potential in the healthcare sector.